Placebo for AZD2693 Solution for Injection, Placebo for AZD2693 Solution for Injection
D7830C00004
Phase 2 small_molecule active
Quick answer
Placebo for AZD2693 Solution for Injection, Placebo for AZD2693 Solution for Injection for Non-cirrhotic non-alcoholic steatohepatitis with fibrosis is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Non-cirrhotic non-alcoholic steatohepatitis with fibrosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active